FDA Grants DOD Emergency Use Authorization For French Freeze-Dried Plasma

July 10, 2018
FDA has granted emergency use authorization to the Department of Defense (DOD) to use freeze-dried plasma manufactured by France’s Armed Forces Blood Transfusion Center (CTSA), the agency announced Tuesday (July 10). The approval comes six months after FDA and DOD’s Office of Health Affairs announced plans to implement a new framework to prioritize development of medical products for use by the war fighter, including by treating DOD medical development programs as if they have received FDA’s breakthrough therapy designation. The...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.